F-group (family)
5002.1.1.1 PRCH
Ligands and drugs
197
Member domains
169
with ligand contacts (≤ 4 Å)
85.8% of members
141
with DrugDomain annotations
71.6% of members
134
with a DrugBank compound
68.0% of members
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
Chemical profiles are computed for X-groups. 5002.1.1.1 belongs to X-group 5002 Photosystem II reaction centre subunit H, transmembrane region, which has 17 proteins with classified ligands. View its chemical profile →
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB03429 | CDL | Tetrastearoyl cardiolipin | 82 |
| DB09270 | U10 | Ubidecarenone | 11 |
| DB01728 | PEF | 1,2-dihexadecanoyl-sn-glycero-3-phosphoethanolamine | 8 |
| DB01853 | BCL | Bacteriochlorophyll A | 2 |
| DB04079 | HTO | Heptane-1,2,3-Triol | 2 |
| DB03152 | BGL | B-2-Octylglucoside | 1 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| CDL | CARDIOLIPIN | 101 |
| PGV | (1R)-2-{[{[(2S)-2,3-DIHYDROXYPROPYL]OXY}(HYDROXY)PHOSPHORYL]OXY}-1-[(PALMITOYLOXY)METHYL]ETHYL (11E)-OCTADEC-11-ENOATE | 21 |
| PC1 | 1,2-DIACYL-SN-GLYCERO-3-PHOSPHOCHOLINE | 12 |
| PEF | DI-PALMITOYL-3-SN-PHOSPHATIDYLETHANOLAMINE | 10 |
| UNL | Unknown ligand | 9 |
| CD4 | (2R,5R,11R,14R)-5,8,11-trihydroxy-5,11-dioxido-17-oxo-2,14-bis(tetradecanoyloxy)-4,6,10,12,16-pentaoxa-5,11-diphosphatriacont-1-yl tetradecanoate | 8 |
| NKP | (2R)-2-hydroxy-3-(phosphonooxy)propyl (9E)-octadec-9-enoate | 7 |
| GGD | NONADEC-10-ENOIC ACID2-[3,4-DIHYDROXY-6-HYDROXYMETHYL-5-(3,4,5-TRIHYDROXY-6-HYDROXYMETHYL-TETRAHYDRO-PYRAN-2-YLOXY)-TETRAHYDRO-PYRAN-2-YLOXY]-1-OCTADEC-9-ENOYLOXYMETHYL-ETHYL ESTER | 6 |
| PGW | (1R)-2-{[(S)-{[(2S)-2,3-dihydroxypropyl]oxy}(hydroxy)phosphoryl]oxy}-1-[(hexadecanoyloxy)methyl]ethyl(9Z)-octadec-9-enoate | 6 |
| 3PE | 1,2-Distearoyl-sn-glycerophosphoethanolamine | 5 |
| 0V9 | (19R,22S)-25-amino-22-hydroxy-22-oxido-16-oxo-17,21,23-trioxa-22lambda~5~-phosphapentacosan-19-yl (9Z)-hexadec-9-enoate | 4 |
| MW9 | (21R,24R,27S)-24,27,28-trihydroxy-18,24-dioxo-19,23,25-trioxa-24lambda~5~-phosphaoctacosan-21-yl (9Z)-octadec-9-enoate | 4 |
| V7B | [(2~{S})-3-[(2~{R},3~{R},4~{R},5~{S},6~{R})-6-(hydroxymethyl)-5-[(2~{R},3~{R},4~{S},5~{S},6~{R})-6-(hydroxymethyl)-3,4,5-tris(oxidanyl)oxan-2-yl]oxy-3,4-bis(oxidanyl)oxan-2-yl]oxy-2-(12-methyltridecanoyloxy)propyl] 12-methyltridecanoate | 4 |
| 8K6 | Octadecane | 3 |
| CL | CHLORIDE ION | 3 |
| PTY | PHOSPHATIDYLETHANOLAMINE | 3 |
| 07D | Trans-Geranyl BACTERIOCHLOROPHYLL A | 2 |
| 6PL | (4S,7R)-4-HYDROXY-N,N,N-TRIMETHYL-9-OXO-7-[(PALMITOYLOXY)METHYL]-3,5,8-TRIOXA-4-PHOSPHAHEXACOSAN-1-AMINIUM 4-OXIDE | 2 |
| BCL | BACTERIOCHLOROPHYLL A | 2 |
| D12 | DODECANE | 2 |